$6.09
+0.21 (+3.57%)
Analyst Consensus
Sell
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+318.6% upside
Low Target
$15.07
Average Target
$25.49
High Target
$30.49
Current Price
$6.09
Current
$6.09
$6.09
Target
$25.49
$25.49
$15.07
$25.49 avg
$30.49
Scenario Analysis
Bear Case
$15.07
147.5%
Low target
Base Case
$25.49
+318.6%
Avg target
Bull Case
$30.49
+400.7%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$24.28
-74.9% from high
52-Week Low
$12.96
+-53.0% from low
Target vs 52W High
$25.49
+5.0% vs high
Next Earnings Report
Mar 3, 2026 · After Market Close
15d
until earnings
EPS Est: $-0.46
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 82% | $369.21 | -32.0% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -27.0% |
| A | Buy | 29 | 72% | $64.69 | -50.1% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -55.8% |
| MTD | Hold | 21 | 43% | $170.43 | -87.6% |
| WAT | Buy | 25 | 56% | $189.60 | -50.3% |
| ILMN | Hold | 26 | 50% | $169.36 | +41.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.3% |